A large number of people living with asthma and COPD still lack access to medicines—an urgent and growing public health challenge. The webinar “Increasing Access to Inhaled Medicines for COPD and Asthma” provided an important opportunity to explore practical strategies for improving access in low- and middle-income countries. It also highlighted valuable lessons from diabetes care that could inform future approaches to the COPD agenda. Listen to leading clinical experts, patients and families, and global health advocates discuss the shocking lack of access to inhaled medicines for most of the 652 million people living with COPD and asthma across the world and must can be done about it.
"In the NCD Policy Lab this is what we have been doing for Diabetes, combining deep technical expertise with ongoing knowledge generation, and then translating that science into policy-relevant action", Marina Giachino. The NCD Policy Lab, represented by Marina Giachino, was pleased to be part of this expert dialogue alongside representatives from the World Health Organization, Forum of International Respiratory Societies (FIRS), NCD Alliance, and others.
REWATCH THE WEBINAR: